SXL
NMTR

Summit X LLC’s 9 Meters Biopharma NMTR Stock Holding History

Summit X LLC’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-640
Closed -$1K – 266
2022
Q3 		$1K Sell
640
-200
-24% -$991 ﹤0.01% 246
2022
Q2 		$5K Hold
840
– – ﹤0.01% 243
2022
Q1 		$10K Buy
840
+250
+42% +$3.41K ﹤0.01% 253
2021
Q4 		$11K Sell
590
-175
-23% -$3.92K ﹤0.01% 258
2021
Q3 		$21K Hold
765
– – 0.01% 258
2021
Q2 		$17K Sell
765
-300
-28% -$7.37K ﹤0.01% 263
2021
Q1 		$24K Sell
1,065
-485
-31% -$14.9K 0.01% 260
2020
Q4 		$20K Buy
+1,550
New +$25.9K 0.01% 246
2020
Q2 		$22K Buy
1,900
+200
+12% +$2.25K 0.01% 206
2020
Q1 		$19K Buy
1,700
+50
+3% +$627 0.01% 188
2019
Q4 		$20K Buy
1,650
+700
+74% +$11.7K 0.01% 227
2019
Q3 		$19K Buy
+950
New +$19.2K 0.01% 225

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $340M AUM 23.31% 1-Year Est. Return

Summit X LLC's NMTR Position: Q4 2022 in Review

Summit X LLC sold out of 9 Meters Biopharma (NMTR) in Q4 2022, closing a stake of 640 shares — an estimated $1K sold.

Summit X LLC first reported a position in NMTR in Q3 2019 and held it in 12 quarters. The position peaked at $24K in Q1 2021. 41 funds tracked by Wall St. Rank hold NMTR as of Q4 2022.

  • Summit X LLC reported no remaining 9 Meters Biopharma position as of Q4 2022 after selling out during the quarter.
  • Summit X LLC sold 640 9 Meters Biopharma shares in Q4 2022, an estimated $1K.
  • Summit X LLC first reported a position in 9 Meters Biopharma in Q3 2019 and held it in 12 quarters.
  • Summit X LLC's 9 Meters Biopharma position peaked at $24K in Q1 2021.
  • 41 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2022.

Based on Summit X LLC's 13F filing for Q4 2022, filed 3 Feb 2023.